Literature DB >> 14574578

Cerebral autoregulation is compromised during simulated fluctuations in gravitational stress.

Clive M Brown1, Matthias Dütsch, Susanne Ohring, Bernhard Neundörfer, Max J Hilz.   

Abstract

Gravity places considerable stress on the cardiovascular system but cerebral autoregulation usually protects the cerebral blood vessels from fluctuations in blood pressure. However, in conditions such as those encountered on board a high-performance aircraft, the gravitational stress is constantly changing and might compromise cerebral autoregulation. In this study we assessed the effect of oscillating orthostatic stress on cerebral autoregulation. Sixteen (eight male) healthy subjects [aged 27 (1) years] were exposed to steady-state lower body negative pressure (LBNP) at -15 and -40 mmHg and then to oscillating LBNP at the same pressures. The oscillatory LBNP was applied at 0.1 and 0.2 Hz. We made continuous recordings of RR-interval, blood pressure, cerebral blood flow velocity (CBFV), respiratory frequency and end-tidal CO(2). Oscillations in mean arterial pressure (MAP) and CBFV were assessed by autoregressive spectral analysis. Respiration was paced at 0.25 Hz to avoid interference from breathing. Steady-state LBNP at -40 mmHg significantly increased low-frequency (LF, 0.03-0.14 Hz) powers of MAP ( P<0.01) but not of CBFV. Oscillatory 0.1 Hz LBNP (0 to -40 mmHg) significantly increased the LF power of MAP to a similar level as steady-state LBNP but also resulted in a significant increase in the LF power of CBFV ( P<0.01). Oscillatory LBNP at 0.2 Hz induced oscillations in MAP and CBFV at 0.2 Hz. Cross-spectral analysis showed that the transfer of LBNP-induced oscillations in MAP onto the CBFV was significantly greater at 0.2 Hz than at 0.1 Hz ( P<0.01). These results show that the ability of the cerebral vessels to modulate fluctuations in blood pressure is compromised during oscillatory compared with constant gravitational stress. Furthermore, this effect seems to be more pronounced at higher frequencies of oscillatory stress.

Entities:  

Mesh:

Year:  2003        PMID: 14574578     DOI: 10.1007/s00421-003-0965-5

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  30 in total

1.  Forearm vascular responses during orthostatic stress in control subjects and patients with posturally related syncope.

Authors:  C M Brown; R Hainsworth
Journal:  Clin Auton Res       Date:  2000-04       Impact factor: 4.435

2.  Critical analysis of cerebrovascular autoregulation during repeated head-up tilt.

Authors:  R L Hughson; M R Edwards; D D O'Leary; J K Shoemaker
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

3.  Impaired cardiovascular responses to baroreflex stimulation in open-angle and normal-pressure glaucoma.

Authors:  Clive M Brown; Matthias Dütsch; Georg Michelson; Bernhard Neundörfer; Max J Hilz
Journal:  Clin Sci (Lond)       Date:  2002-06       Impact factor: 6.124

4.  The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man.

Authors:  J Olesen
Journal:  Neurology       Date:  1972-09       Impact factor: 9.910

5.  Synchronous and baroceptor-sensitive oscillations in skin microcirculation: evidence for central autonomic control.

Authors:  L Bernardi; D Hayoz; R Wenzel; C Passino; A Calciati; R Weber; G Noll
Journal:  Am J Physiol       Date:  1997-10

6.  Orthostatic intolerance and motion sickness after parabolic flight.

Authors:  T T Schlegel; T E Brown; S J Wood; E W Benavides; R L Bondar; F Stein; P Moradshahi; D L Harm; J M Fritsch-Yelle; P A Low
Journal:  J Appl Physiol (1985)       Date:  2001-01

7.  Spectral and cross-spectral autoregressive analysis of cardiovascular variables in subjects with different degrees of orthostatic tolerance.

Authors:  G Gulli; V L Wight; R Hainsworth; A Cevese
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

8.  Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.

Authors:  B J Carey; B N Manktelow; R B Panerai; J F Potter
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

9.  Phase relationship between cerebral blood flow velocity and blood pressure. A clinical test of autoregulation.

Authors:  R R Diehl; D Linden; D Lücke; P Berlit
Journal:  Stroke       Date:  1995-10       Impact factor: 7.914

10.  Comparison of flow and velocity during dynamic autoregulation testing in humans.

Authors:  D W Newell; R Aaslid; A Lam; T S Mayberg; H R Winn
Journal:  Stroke       Date:  1994-04       Impact factor: 7.914

View more
  5 in total

1.  Cerebral blood velocity regulation during progressive blood loss compared with lower body negative pressure in humans.

Authors:  Caroline A Rickards; Blair D Johnson; Ronée E Harvey; Victor A Convertino; Michael J Joyner; Jill N Barnes
Journal:  J Appl Physiol (1985)       Date:  2015-07-02

2.  Coupling between arterial pressure, cerebral blood velocity, and cerebral tissue oxygenation with spontaneous and forced oscillations.

Authors:  Caroline A Rickards; Justin D Sprick; Hannah B Colby; Victoria L Kay; Yu-Chieh Tzeng
Journal:  Physiol Meas       Date:  2015-03-23       Impact factor: 2.833

Review 3.  Integrative physiological and computational approaches to understand autonomic control of cerebral autoregulation.

Authors:  Can Ozan Tan; J Andrew Taylor
Journal:  Exp Physiol       Date:  2013-10-04       Impact factor: 2.969

4.  Assessing cerebral autoregulation via oscillatory lower body negative pressure and projection pursuit regression.

Authors:  J Andrew Taylor; Can Ozan Tan; J W Hamner
Journal:  J Vis Exp       Date:  2014-12-10       Impact factor: 1.355

5.  Slow sinusoidal tilt movements demonstrate the contribution to orthostatic tolerance of cerebrospinal fluid movement to and from the spinal dural space.

Authors:  Wim J Stok; John M Karemaker; Janneke Berecki-Gisolf; Rogier V Immink; Johannes J van Lieshout
Journal:  Physiol Rep       Date:  2019-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.